Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.230
-0.060 (-4.65%)
At close: Mar 3, 2026, 4:00 PM EST
1.250
+0.020 (1.63%)
After-hours: Mar 3, 2026, 7:13 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $5.84 million as of March 3, 2026. Its market cap has increased by 50.71% in one year.
Market Cap
5.84M
Enterprise Value
-4.11M
1-Year Change
50.71%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $5.84M, a decrease of -93.55%. That is a compound annual growth rate of -40.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.84M | 23.24% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 6.96M |
| XTL Biopharmaceuticals | 6.64M |
| Immuron | 6.49M |
| Aprea Therapeutics | 6.41M |
| Aptorum Group | 6.35M |
| Creative Medical Technology Holdings | 6.33M |
| Can-Fite BioPharma | 6.00M |
| Purple Biotech | 5.94M |